We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

224-year-old Smallpox Treatment Modified for COVID-19 Candidate Vaccine
Industry Insight

Vaccine development is a science over 200 years in the making, but creating a preventative that is effective and safe remains a complex and challenging task. Among the many companies working to create a vaccine for COVID-19 is Tonix Pharmaceuticals. Their pre-clinical candidate vaccine uses a unique platform that sets it apart from other efforts to fight the pandemic. We spoke to Tonix CEO Seth Lederman to find out more.

Read More

Using Fast-growing Tobacco Plants To Develop a COVID-19 Vaccine
Industry Insight

Technology Networks recently spoke to David O’Reilly, PhD, Director of Scientific Research at BAT to learn more about the tobacco plant “biomanufacturing factories” that are being used to develop a COVID-19 vaccine. We also discuss the challenges faced when developing a vaccine and the benefits tobacco plants offer compared to conventional vaccine development methods.

Read More

Developing Personalized Strategies To Maximize Cancer Therapy Success
Industry Insight

Technology Networks recently spoke with Ofer Sharon, CEO of OncoHost, to learn more about ways to overcome patient resistance to immunotherapy and how proteomic profiling in oncology can aid diagnosis, prognosis and treatment of this incredibly complex disease.

Read More

Maintaining Optimal Blood Volume in COVID-19 Patients
Industry Insight

Technology Networks spoke to Michael Feldschuh, CEO, Daxor, to learn more about the importance of maintaining optimal blood volume, how the BVA-100 test can help to measure this, and how clinicians can use the information it provides to guide treatment of COVID-19 patients.

Read More

Developing Antibodies and Antigens for COVID-19 Diagnostics
Industry Insight

Technology Networks recently spoke to Dr Andy Lane, Commercial Director, The Native Antigen Company, to learn how SARS-CoV-2 antigens and antibodies can be used to drive the development of COVID-19 diagnostics.

Read More

Which Vaccines Against COVID-19 Are in Human Clinical Trials?
Industry Insight

Here, we outline which vaccine candidates against COVID-19 are currently in human clinical trials.

Read More

Repurposing Drugs To Treat COVID-19 – Benefits and Challenges
Industry Insight

Whilst scientists work tirelessly to develop an effective COVID-19 vaccine as a long-term preventive strategy, in parallel, researchers are also exploring the therapeutic potential of existing drugs as an efficient immediate approach. We recently had the pleasure of speaking with Alan Fletcher, VP/GM, Life Sciences at PerkinElmer, Inc. to learn about the benefits and challenges of repurposing a drug in this context.

Read More

This Digital Pharmacy Aims to Deliver Prescriptions to Your Door During the COVID-19 Pandemic
Industry Insight

The COVID-19 outbreak has accelerated the digitization of healthcare. “Digital pharmacy” Genius Rx says it will trial same-day couriered delivery of scripts to patients’ doors from this summer. We spoke to Randy about the process of getting medication online and how analytics technology could save patients money.

Read More

COVID-19 Vaccine Development: An Interview With GeoVax
Industry Insight

Technology Networks spoke with David Dodd, President and CEO of GeoVax, to learn more about the vaccine candidates against COVID-19, what progress has been made in clinical testing and how the company is working to accelerate vaccine development timeframes.

Read More

Scaling Up Primer and Probe Kits for COVID-19 Testing
Industry Insight

Technology Networks spoke to Trey Martin, President, IDT, to find out exactly how primers and probes work, and learn about the important role they can play in COVID-19 testing.

Read More

 
Advertisement